INmune Bio, Inc. (INMB) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

INmune Bio, Inc. (INMB) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

INMB Cash Flow Statement

INmune Bio, Inc. (INMB) cash flow statement — 11-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-3.39M	-3.17M	-3.4M	-2.96M	-5.44M	-7.38M	-6.82M	-11.01M	-6.99M	-7.89M	-7.48M	-3.4M	-4.26M	-3.17M	-1.14M	-5.7M	-3.37M	-4.76M	-8.87M	-9.78M
Operating CF Margin %	-	-	-	-	-	-	-13648%	-	-	-	-53400%	-12146.43%	-9916.28%	-6900%	-3002.63%	-5871.13%	-3435.71%	-29743.75%	-5438.65%	-6000%
Operating CF Growth %	37.65%	56.95%	50.13%	73.17%	22.14%	6.48%	8.72%	-223.82%	-63.84%	-148.46%	-555.21%	40.28%	-26.64%	33.31%	87.13%	41.77%	57.5%	16.64%	-74.1%	-308.74%
Net Income	-4.72M	-1.27M	-5.41M	40.75M	-6.47M	-24.46M	-9.74M	-9.22M	-12.09M	-9.75M	-11.03M	-8.41M	-8.56M	-6.5M	-6.54M	-5.83M	-7.72M	-6.84M	-6.9M	-9.67M
Depreciation & Amortization	73K	66K	52K	56K	0	0	0	0	15K	24K	34K	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	1.12M	1.36M	1.5M	-6.59M	2.98M	1.53M	2.08M	1.76M	1.72M	2.35M	1.78M	1.88M	1.89M	1.86M	1.74M	1.79M	1.94M	1.89M	1.54M	1.52M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-2.65M	0	-91K	-36.11M	-598K	16.51M	0	6K	0	0	34K	45K	54K	58K	67K	68K	147K	57K	56K	57K
Working Capital Changes	2.78M	-3.33M	546K	-1.05M	-1.35M	-965K	839K	-3.56M	3.37M	-514K	1.74M	3.08M	2.36M	1.41M	3.59M	-1.72M	2.27M	136K	-3.55M	-1.69M
Change in Receivables	226K	-4M	3.77M	-2.08M	-309K	-739K	-7K	11K	1.99M	-723K	-248K	-179K	-217K	164K	6.25M	-3.93M	529K	588K	-144K	-358K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	-164K	-6.25M	0	-529K	0	0	0
Change in Payables	2.53M	394K	-3.02M	893K	-329K	554K	737K	-4.08M	1.22M	71K	1.41M	4.18M	1.36M	308K	-3.13M	1.74M	1.78M	-864K	-1.25M	-418K
Cash from Investing	430K	-430K	0	-143K	-193K	-706K	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	430K	-430K	0	-706K	-193K	-706K	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	563K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	1.33M	749K	0	67K	0	22.27M	5.27M	-2.08M	9.79M	13M	-2.5M	-2.5M	-1.73M	0	0	0	0	0	729K	0
Debt Issued (Net)	0	0	0	0	0	0	0	-2.5M	-2.5M	-2.5M	-2.5M	-2.5M	-2.5M	0	0	0	0	0	0	0
Equity Issued (Net)	0	749K	0	67K	0	22.27M	5.27M	0	12.29M	15.5M	0	0	775K	0	0	0	0	0	699K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	1.33M	0	0	0	0	0	0	422K	0	0	0	0	0	0	0	0	0	0	30K	0
Net Change in Cash	-2.08M	-2.95M	-3.39M	-2.98M	-5.64M	14.04M	-1.58M	-12.63M	2.48M	5.07M	-9.85M	-5.96M	-6.01M	-3.18M	-1.15M	-5.25M	-3.81M	-5.52M	-8.08M	-9.66M
Free Cash Flow	-2.96M	-3.6M	-3.4M	-3.66M	-5.63M	-8.08M	-6.82M	-11.01M	-6.99M	-7.89M	-7.48M	-3.4M	-4.26M	-3.17M	-1.14M	-5.7M	-3.37M	-4.76M	-8.87M	-9.78M
FCF Margin %	-	-	-	-	-	-	-13648%	-	-	-	-53400%	-12146.43%	-9916.28%	-6900%	-3002.63%	-5871.13%	-3435.71%	-29743.75%	-5438.65%	-6000%
FCF Growth %	47.43%	55.39%	50.13%	66.76%	19.38%	-2.47%	8.72%	-223.82%	-63.84%	-148.46%	-555.21%	40.28%	-26.64%	33.31%	87.13%	41.77%	57.5%	16.64%	-74.1%	-308.74%
FCF per Share	-0.11	-0.13	-0.13	-0.14	-0.21	-0.35	-0.30	-0.49	-0.35	-0.41	-0.41	-0.19	-0.24	-0.18	-0.06	-0.32	-0.19	-0.27	-0.50	-0.56
FCF Conversion (FCF/Net Income)	0.72x	2.49x	0.63x	0.56x	0.84x	0.30x	0.70x	1.19x	0.58x	0.81x	0.68x	0.40x	0.50x	0.49x	0.17x	0.98x	0.44x	0.70x	1.28x	1.01x
Interest Paid	0	0	0	0	0	0	0	1.03M	0	0	0	384K	464K	0	0	410K	0	310K	291K	294K
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0